GHSI חוב כולל להון Guardion Health

The success of Guardion Health Science (GHSI) relies on physician trust and the availability of medications in pharmacies. Its narrow specialization in ophthalmic supplements is currently being adjusted through the sale of non-core assets. The confirmed price history on the GURU.Markets platform chart shows that the debt-to-equity ratio is 0.00. Looking ahead, Guardion Health Science (GHSI) plans to expand B2B sales to secure a dominant position in the specialized vision nutraceuticals segment.

Guardion Health Science specializes in niche nutraceuticals for the treatment of glaucoma, leveraging expert ophthalmologist recommendations to bypass mass-market competition. The total liabilities-to-equity ratio determines the business's financial autonomy, allowing investors to assess bankruptcy risk and the efficiency of leverage management through changes in the proportion of debt to equity.